Review



chlorambucil (c0253)  (Millipore)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Millipore chlorambucil (c0253)
    The release of <t>chlorambucil</t> from F127-folate@PLGA/CHL/IR780 and F127@PLGA/CHL/IR780 after 24, 48, 72, and 168 h of incubation in 0.1× PBS (NaCl 13.7 mM, KCl 0.27 mM, NaH 2 PO 4 1 mM, and KHPO 4 0.18 mM) at pH 7.4 and pH 5.4 at 37 °C; n = 3.
    Chlorambucil (C0253), supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/chlorambucil (c0253)/product/Millipore
    Average 90 stars, based on 1 article reviews
    chlorambucil (c0253) - by Bioz Stars, 2026-02
    90/100 stars

    Images

    1) Product Images from "Therapeutic effect of F127-folate@PLGA/CHL/IR780 nanoparticles on folate receptor-expressing cancer cells"

    Article Title: Therapeutic effect of F127-folate@PLGA/CHL/IR780 nanoparticles on folate receptor-expressing cancer cells

    Journal: Beilstein Journal of Nanotechnology

    doi: 10.3762/bjnano.15.78

    The release of chlorambucil from F127-folate@PLGA/CHL/IR780 and F127@PLGA/CHL/IR780 after 24, 48, 72, and 168 h of incubation in 0.1× PBS (NaCl 13.7 mM, KCl 0.27 mM, NaH 2 PO 4 1 mM, and KHPO 4 0.18 mM) at pH 7.4 and pH 5.4 at 37 °C; n = 3.
    Figure Legend Snippet: The release of chlorambucil from F127-folate@PLGA/CHL/IR780 and F127@PLGA/CHL/IR780 after 24, 48, 72, and 168 h of incubation in 0.1× PBS (NaCl 13.7 mM, KCl 0.27 mM, NaH 2 PO 4 1 mM, and KHPO 4 0.18 mM) at pH 7.4 and pH 5.4 at 37 °C; n = 3.

    Techniques Used: Incubation

    Cell viability of HepG2 and MCF-7. Control: cells received no treatment; the chlorambucil-treated cell at CHL concentrations of 6.57 μM, 13.14 μM, and 19.71 μM; F127-folate@PLGA/CHL/IR780; and F127@PLGA/CHL/IR780 at 0.5 mg/mL, 1 mg/mL, and 1.5 mg/mL. Cells were incubated for 48 h (red) and 72 h (blue). Initial cell inoculation: 1000 cells/well; n = 4, * p < 0.05.
    Figure Legend Snippet: Cell viability of HepG2 and MCF-7. Control: cells received no treatment; the chlorambucil-treated cell at CHL concentrations of 6.57 μM, 13.14 μM, and 19.71 μM; F127-folate@PLGA/CHL/IR780; and F127@PLGA/CHL/IR780 at 0.5 mg/mL, 1 mg/mL, and 1.5 mg/mL. Cells were incubated for 48 h (red) and 72 h (blue). Initial cell inoculation: 1000 cells/well; n = 4, * p < 0.05.

    Techniques Used: Control, Incubation



    Similar Products

    chlorambucil (c0253)  (Millipore)
    90
    Millipore chlorambucil (c0253)
    The release of <t>chlorambucil</t> from F127-folate@PLGA/CHL/IR780 and F127@PLGA/CHL/IR780 after 24, 48, 72, and 168 h of incubation in 0.1× PBS (NaCl 13.7 mM, KCl 0.27 mM, NaH 2 PO 4 1 mM, and KHPO 4 0.18 mM) at pH 7.4 and pH 5.4 at 37 °C; n = 3.
    Chlorambucil (C0253), supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/chlorambucil (c0253)/product/Millipore
    Average 90 stars, based on 1 article reviews
    chlorambucil (c0253) - by Bioz Stars, 2026-02
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    The release of chlorambucil from F127-folate@PLGA/CHL/IR780 and F127@PLGA/CHL/IR780 after 24, 48, 72, and 168 h of incubation in 0.1× PBS (NaCl 13.7 mM, KCl 0.27 mM, NaH 2 PO 4 1 mM, and KHPO 4 0.18 mM) at pH 7.4 and pH 5.4 at 37 °C; n = 3.

    Journal: Beilstein Journal of Nanotechnology

    Article Title: Therapeutic effect of F127-folate@PLGA/CHL/IR780 nanoparticles on folate receptor-expressing cancer cells

    doi: 10.3762/bjnano.15.78

    Figure Lengend Snippet: The release of chlorambucil from F127-folate@PLGA/CHL/IR780 and F127@PLGA/CHL/IR780 after 24, 48, 72, and 168 h of incubation in 0.1× PBS (NaCl 13.7 mM, KCl 0.27 mM, NaH 2 PO 4 1 mM, and KHPO 4 0.18 mM) at pH 7.4 and pH 5.4 at 37 °C; n = 3.

    Article Snippet: Chlorambucil (C0253), PLGA 504H (719900), IR780 (425311), Pluronic™ F-127 (P2443), poly(vinyl alcohol) (PVA) (P8136), phosphate buffered saline (PBS) (P4417), dimethyl sulfoxide (DMSO) (472301), dichloromethane (DCM), 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl-2 H -tetrazolium bromide (MTT) (M2128), coumarin-6 (Cou-6) (442631), folic acid (1039840005) and 1,1-carbonyldiimidazole (115533) were purchased from Sigma-Aldrich.

    Techniques: Incubation

    Cell viability of HepG2 and MCF-7. Control: cells received no treatment; the chlorambucil-treated cell at CHL concentrations of 6.57 μM, 13.14 μM, and 19.71 μM; F127-folate@PLGA/CHL/IR780; and F127@PLGA/CHL/IR780 at 0.5 mg/mL, 1 mg/mL, and 1.5 mg/mL. Cells were incubated for 48 h (red) and 72 h (blue). Initial cell inoculation: 1000 cells/well; n = 4, * p < 0.05.

    Journal: Beilstein Journal of Nanotechnology

    Article Title: Therapeutic effect of F127-folate@PLGA/CHL/IR780 nanoparticles on folate receptor-expressing cancer cells

    doi: 10.3762/bjnano.15.78

    Figure Lengend Snippet: Cell viability of HepG2 and MCF-7. Control: cells received no treatment; the chlorambucil-treated cell at CHL concentrations of 6.57 μM, 13.14 μM, and 19.71 μM; F127-folate@PLGA/CHL/IR780; and F127@PLGA/CHL/IR780 at 0.5 mg/mL, 1 mg/mL, and 1.5 mg/mL. Cells were incubated for 48 h (red) and 72 h (blue). Initial cell inoculation: 1000 cells/well; n = 4, * p < 0.05.

    Article Snippet: Chlorambucil (C0253), PLGA 504H (719900), IR780 (425311), Pluronic™ F-127 (P2443), poly(vinyl alcohol) (PVA) (P8136), phosphate buffered saline (PBS) (P4417), dimethyl sulfoxide (DMSO) (472301), dichloromethane (DCM), 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl-2 H -tetrazolium bromide (MTT) (M2128), coumarin-6 (Cou-6) (442631), folic acid (1039840005) and 1,1-carbonyldiimidazole (115533) were purchased from Sigma-Aldrich.

    Techniques: Control, Incubation